DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats ENA Respiratory has been awarded ...
Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats ENA Respiratory has been awarded ...
The U.S. Donates Another 10 Million Pfizer Vaccines to Bangladesh; U.S.-Donated Doses Now Exceed 38 Million The U.S. donated an ...
Advancements in biomanufacturing are bringing on-demand, shelf-stable vaccines to the front lines. By the year 2050, it is estimated that ...
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 – and ...
Just like a fresh piece of fish, vaccines are highly perishable products and must be kept at very cold, specific ...
Amid unpredictable outbreaks, and fears of a second wave, the hunt is on for a vaccine against COVID-19. The reason ...
Bavarian Nordic A/S announced on Jan. 18 that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised another ...
Soligenix, Inc. announced today that it has been granted a Japanese patent (number 6110845) further extending protection around ThermoVax including ...
Soligenix, Inc. this week announced positive preliminary proof-of-concept results from its collaboration with University of Hawaiʻi at Mānoa (UH Mānoa) ...
Soligenix, Inc. today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised an option for RiVax™ ...
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in ...
Soligenix, Inc. today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to advance ...
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical and biopharmaceutical product developers on multivalent ...
Soligenix, Inc., a late-stage biopharmaceutical company developing products in the areas of biodefense, inflammation, and oncology, today announced highlights and ...
The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are soliciting research and development ...
Soligenix, Inc. last week announced a collaboration agreement with Axel Lehrer, PhD, of the UH Mānoa Department of Tropical Medicine, ...
The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda ...
Advanced development is underway on an improved anthrax vaccine that could provide protection in fewer doses than the currently licensed ...
Officials from the U.S. Department of Health and Human Services commented last week on the accelerated development of two promising ...
A rapid, point-of-care diagnostic test for the Ebola virus will be trialed in the coming weeks at the Ebola treatment ...